Abstract
The incorporation of information on genetic testing into the product label of the anticoagulant warfarin and the FDA marketing clearance for an associated test represent a significant advance for the field of pharmacogenetics.
This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Jones, D. Steps on the road to personalized medicine. Nat Rev Drug Discov 6, 770–771 (2007). https://doi.org/10.1038/nrd2434
Issue Date:
DOI: https://doi.org/10.1038/nrd2434
- Springer Nature Limited
This article is cited by
-
Ontology-based disease similarity network for disease gene prediction
Vietnam Journal of Computer Science (2016)
-
First oral warfarin alternative approved in the US
Nature Reviews Drug Discovery (2010)
-
2007: Spotlight on drug safety
Nature Reviews Drug Discovery (2008)
-
Assessing the Value-Adding Impact of Diagnostic-Type Tests on Drug Development and Marketing
Molecular Diagnosis & Therapy (2008)